Furthermore, PI3KCA activating mutations common in many cancers have been detected in ≤3% of melanomas [18, 19], while recently GNAQ/GNA11 mutations have been detected in uveal melanomas in up to 34–48% [20] compared to <1% of cutaneous melanomas [13]. The gene discussed is GNAQ; the disease is cutaneous melanoma.